SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Epigenetic therapy as a novel approach in hepatocellular carcinoma, Pharmacology & Therapeutics, 2015, 145, 103

    CrossRef

  2. 2
    Jean-Pierre Issa, Aging and epigenetic drift: a vicious cycle, Journal of Clinical Investigation, 2014, 124, 1, 24

    CrossRef

  3. 3
    Yoshifumi Baba, Asuka Murata, Masayuki Watanabe, Hideo Baba, Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer, Surgery Today, 2014, 44, 10, 1807

    CrossRef

  4. 4
    Elias Jabbour, Guillermo Garcia-Manero, Deacetylase Inhibitors for the Treatment of Myelodysplastic Syndromes, Leukemia & Lymphoma, 2014, 1

    CrossRef

  5. 5
    Fatima el Bahhaj, Frank J. Dekker, Nadine Martinet, Philippe Bertrand, Delivery of epidrugs, Drug Discovery Today, 2014, 19, 9, 1337

    CrossRef

  6. 6
    Priscilla Brebi, Rene Hoffstetter, Alejandra Andana, Carmen G. Ili, Kathleen Saavedra, Tamara Viscarra, Javier Retamal, Raul Sanchez, Juan C. Roa, Evaluation ofZAR1andSFRP4methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I, Biomarkers, 2014, 19, 3, 181

    CrossRef

  7. 7
    Wei Xiao, Ji Wang, Heng Li, Ding Xia, Gan Yu, Weimin Yao, Yang Yang, Haibing Xiao, Bin Lang, Xin Ma, Xiaolin Guo, Wei Guan, Hua Xu, Jihong Liu, Xu Zhang, Zhangqun Ye, Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence, BMC Cancer, 2014, 14, 1, 677

    CrossRef

  8. 8
    Agnieszka Stembalska, Przemysław Leszczyński, Justyna Gil, David Ramsey, Grzegorz Pitala, Adam Maciejczyk, Marcin Frączek, Global DNA methylation status in laryngeal cancer, Head & Neck, 2014, 36, 3
  9. 9
    Andrey Poleshko, Andrew V Kossenkov, Natalia Shalginskikh, Anna Pecherskaya, Anna Pecherskaya, Margret B Einarson, Margret B Einarson, Anna Marie Skalka, Anna Marie Skalka, Richard A Katz, Richard A Katz, Human factors and pathways essential for mediating epigenetic gene silencing, Epigenetics, 2014, 9, 9, 1280

    CrossRef

  10. 10
    Asuka Murata, Yoshifumi Baba, Masayuki Watanabe, Hironobu Shigaki, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Shiro Iwagami, Naoya Yoshida, Eiji Oki, Masaru Morita, Mitsuyoshi Nakao, Hideo Baba, IGF2 DMR0 Methylation, Loss of Imprinting, and Patient Prognosis in Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, 2014, 21, 4, 1166

    CrossRef

  11. 11
    S M Tajuddin, A F S Amaral, A F Fernández, S Chanock, D T Silverman, A Tardón, A Carrato, M García-Closas, B P Jackson, E G Toraño, M Márquez, R G Urdinguio, R García-Closas, N Rothman, M Kogevinas, F X Real, M F Fraga, N Malats, M Kogevinas, N Malats, F X Real, M Sala, G Castaño, M Torà, D Puente, C Villanueva, C Murta-Nascimento, J Fortuny, E López, S Hernández, R Jaramillo, G Vellalta, L Palencia, F Fermández, A Amorós, A Alfaro, G Carretero, J Lloreta, S Serrano, L Ferrer, A Gelabert, J Carles, O Bielsa, K Villadiego, L Cecchini, J M Saladié, L Ibarz, M Céspedes, C Serra, D García, J Pujadas, R Hernando, A Cabezuelo, C Abad, A Prera, J Prat, M Domènech, J Badal, J Malet, R García-Closas, J Rodríguez de Vera, A I Martín, J Taño, F Cáceres, A Carrato, F García-López, M Ull, A Teruel, E Andrada, A Bustos, A Castillejo, J L Soto, A Tardón, J L Guate, J M Lanzas, J Velasco, J M Fernández, J J Rodríguez, A Herrero, R Abascal, C Manzano, T Miralles, M Rivas, M Arguelles, M Díaz, J Sánchez, O González, A Mateos, V Frade, Mieres Asturias, P Muntañola, C Pravia, A M Huescar, F Huergo, J Mosquera, LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk, British Journal of Cancer, 2014, 110, 8, 2123

    CrossRef

  12. 12
    Xiaoqiang Guo, Jiazeng Xia, Kaiyuan Deng, Long non-coding RNAs: emerging players in gastric cancer, Tumor Biology, 2014, 35, 11, 10591

    CrossRef

  13. 13
    Hui Fan, Xuechun Lu, Xiaohui Wang, Yang Liu, Bo Guo, Yan Zhang, Wenying Zhang, Jing Nie, Kaichao Feng, Meixia Chen, Yajing Zhang, Yao Wang, Fengxia Shi, Xiaobing Fu, Hongli Zhu, Weidong Han, Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  14. 14
    Bi-Feng Chen, Shen Gu, Yick-Keung Suen, Lu Li, Wai-Yee Chan, microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer, Epigenetics, 2014, 9, 1, 119

    CrossRef

  15. 15
    Chao Ding, Cunlong Zhang, Mingli Zhang, Yu Zong Chen, Chunyan Tan, Ying Tan, Yuyang Jiang, Multitarget inhibitors derived from crosstalk mechanism involving VEGFR2, Future Medicinal Chemistry, 2014, 6, 16, 1771

    CrossRef

  16. 16
    A. B. Crujeiras, F. F. Casanueva, Obesity and the reproductive system disorders: epigenetics as a potential bridge, Human Reproduction Update, 2014,

    CrossRef

  17. 17
    Nathalie Egalite, Iris Jaitovich Groisman, Beatrice Godard, Personalized medicine in oncology: ethical implications for the delivery of healthcare, Personalized Medicine, 2014, 11, 7, 659

    CrossRef

  18. 18
    Bryan Oronsky, Neil Oronsky, Jan Scicinski, Gary Fanger, Michelle Lybeck, Tony Reid, Rewriting the Epigenetic Code for Tumor Resensitization: A Review, Translational Oncology, 2014, 7, 5, 626

    CrossRef

  19. 19
    S.N. Dumont, D. Yang, A.G. Dumont, D. Reynoso, J-Y. Blay, J.C. Trent, Targeted polytherapy in small cell sarcoma and its association with doxorubicin, Molecular Oncology, 2014, 8, 8, 1458

    CrossRef

  20. 20
    Annie Moradian, Anastasia Kalli, Michael J. Sweredoski, Sonja Hess, The top-down, middle-down, and bottom-up mass spectrometry approaches for characterization of histone variants and their post-translational modifications, PROTEOMICS, 2014, 14, 4-5
  21. 21
    Yoshifumi Baba, Masayuki Watanabe, Hideo Baba, A review of the alterations in DNA methylation in esophageal squamous cell carcinoma, Surgery Today, 2013, 43, 12, 1355

    CrossRef

  22. 22
    Sibaji Sarkar, Garrick Horn, Kimberly Moulton, Anuja Oza, Shannon Byler, Shannon Kokolus, McKenna Longacre, Cancer Development, Progression, and Therapy: An Epigenetic Overview, International Journal of Molecular Sciences, 2013, 14, 10, 21087

    CrossRef

  23. 23
    Hanfeng Guan, Linka Xie, Kay Klapproth, Clarissa D Weitzer, Thomas Wirth, Alexey Ushmorov, Decitabine represses translocated MYC oncogene in Burkitt lymphoma, The Journal of Pathology, 2013, 229, 5
  24. 24
    M.A. Romero-Tlalolini, P. Chávez Olmos, Efraín Garrido, Differential DNA methylation patterns in the CD86 gene controls its constitutive expression in keratinocytes, Biochemical and Biophysical Research Communications, 2013, 438, 1, 54

    CrossRef

  25. 25
    Jumpei Yamazaki, Jean-Pierre J. Issa, Epigenetic aspects of MDS and its molecular targeted therapy, International Journal of Hematology, 2013, 97, 2, 175

    CrossRef

  26. 26
    Wei Xiao, Ji Wang, Heng Li, Wei Guan, Ding Xia, Gan Yu, Haibing Xiao, Bin Lang, Xin Ma, Jihong Liu, Xu Zhang, Zhangqun Ye, Hua Xu, Fibulin-1 is Down-Regulated Through Promoter Hypermethylation and Suppresses Renal Cell Carcinoma Progression, The Journal of Urology, 2013, 190, 1, 291

    CrossRef

  27. 27
    Jen-Hao Chen, Kun-Tu Yeh, Yu-Min Yang, Jan-Gowth Chang, Huey-Er Lee, Shih-Ya Hung, High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan, Medical Oncology, 2013, 30, 2

    CrossRef

  28. 28
    Xiaoming Zhu, Hongjiang Wang, Fan Liu, Li Chen, Weijia Luo, Pixiong Su, Weiming Li, Liping Yu, Xinchun Yang, Jun Cai, Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy, Journal of Cellular and Molecular Medicine, 2013, 17, 9
  29. 29
    Hironobu Shigaki, Yoshifumi Baba, Masayuki Watanabe, Asuka Murata, Shiro Iwagami, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Hideo Baba, LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis, Gastric Cancer, 2013, 16, 4, 480

    CrossRef

  30. 30
    Shiro Iwagami, Yoshifumi Baba, Masayuki Watanabe, Hironobu Shigaki, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Kentaro Sakamaki, Yasuo Ohashi, Hideo Baba, LINE-1 Hypomethylation Is Associated With a Poor Prognosis Among Patients With Curatively Resected Esophageal Squamous Cell Carcinoma, Annals of Surgery, 2013, 257, 3, 449

    CrossRef

  31. 31
    Victor Valdespino, Patricia M Valdespino, Victor Valdespino Junio, Main Phenotype Subphases in Reprogramming Somatic Cells as a Model of Cellular Differentiation Process, American Journal of Biomedical Research, 2013, 1, 3, 48

    CrossRef

  32. 32
    Yu. A. Bukurova, G. S. Krasnov, I. G. Nikitina, V. L. Karpov, N. A. Lisitsyn, S. F. Beresten, Methods of searching for markers for serological serum diagnosis of tumors, Molecular Biology, 2013, 47, 1, 1

    CrossRef

  33. 33
    A Murata, Y Baba, M Watanabe, H Shigaki, K Miyake, T Ishimoto, M Iwatsuki, S Iwagami, Y Sakamoto, Y Miyamoto, N Yoshida, K Nosho, H Baba, Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer, British Journal of Cancer, 2013, 109, 2, 408

    CrossRef

  34. 34
    Nanne K. Kloosterhof, Johan J. Rooi, Max Kros, Paul H. C. Eilers, Peter A. E. Sillevis Smitt, Martin J. Bent, Pim J. French, Molecular subtypes of glioma identified by genome-wide methylation profiling, Genes, Chromosomes and Cancer, 2013, 52, 7
  35. 35
    A. B. Crujeiras, A. Díaz-Lagares, M. C. Carreira, M. Amil, F. F. Casanueva, Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer, Free Radical Research, 2013, 47, 4, 243

    CrossRef

  36. 36
    Metin Karahoca, Richard L Momparler, Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy, Clinical Epigenetics, 2013, 5, 1, 3

    CrossRef

  37. 37
    A. Roy, N. Roy Chattopadhyay, Reasons of carcinogenesis indicate a big-bang inside: A hypothesis for the aberration of DNA methylation, Medical Hypotheses, 2013, 81, 1, 50

    CrossRef

  38. 38
    Patricia García-Domínguez, Carmela Dell’Aversana, Rosana Alvarez, Lucia Altucci, Ángel R. de Lera, Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 6, 1631

    CrossRef

  39. 39
    Yanyun Wang, Lili Qu, Lailing Gong, Li Sun, Rujun Gong, Jin Si, Targeting and Eradicating Hepatic Cancer Cells with a Cancer-Specific Vector Carrying the Buforin II Gene, Cancer Biotherapy & Radiopharmaceuticals, 2013, 28, 8, 623

    CrossRef

  40. 40
    Michael Fleischhacker, Dimo Dietrich, Volker Liebenberg, John K Field, Bernd Schmidt, The role of DNA methylation as biomarkers in the clinical management of lung cancer, Expert Review of Respiratory Medicine, 2013, 7, 4, 363

    CrossRef

  41. 41
    Hisashi Takino, Chunmei Li, Seiji Yamada, Fumihiko Sato, Ayako Masaki, Yukio Fujiyoshi, Hideo Hattori, Hiroshi Inagaki, Thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a gene methylation study, Leukemia & Lymphoma, 2013, 54, 8, 1742

    CrossRef

  42. 42
    Hon-Yi Lin, Tze-Ta Huang, Moon-Sing Lee, Shih-Kai Hung, Ru-Inn Lin, Chih-En Tseng, Shu-Mei Chang, Wen-Yen Chiou, Feng-Chun Hsu, Wen-Lin Hsu, Dai-Wei Liu, Yu-Chieh Su, Szu-Chi Li, Michael W.Y. Chan, Unexpected close surgical margin in resected buccal cancer: Very close margin and DAPK promoter hypermethylation predict poor clinical outcomes, Oral Oncology, 2013, 49, 4, 336

    CrossRef

  43. 43
    Rosanna Weksberg, Darci T. Butcher, Daria Grafodatskaya, Sanaa Choufani, Benjamin Tycko, Emery and Rimoin's Principles and Practice of Medical Genetics, 2013,

    CrossRef

  44. 44
    Tabitha Hardy, Trygve Tollefsbol, Inflammation, Oxidative Stress, and Cancer, 2013,

    CrossRef

  45. 45
    William L. Carroll, Elizabeth A. Raetz, Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia, The Journal of Pediatrics, 2012, 160, 1, 10

    CrossRef

  46. 46
    F Cherblanc, N Chapman-Rothe, R Brown, MJ Fuchter, Current limitations and future opportunities for epigenetic therapies, Future Medicinal Chemistry, 2012, 4, 4, 425

    CrossRef

  47. 47
    André Nogueira da Costa, Zdenko Herceg, Detection of cancer-specific epigenomic changes in biofluids: Powerful tools in biomarker discovery and application, Molecular Oncology, 2012, 6, 6, 704

    CrossRef

  48. 48
    Cheng Wang, Creston J. Flemming, Yi-Qiang Cheng, Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264, MedChemComm, 2012, 3, 8, 976

    CrossRef

  49. 49
    Thomas Mikeska, Christoph Bock, Hongdo Do, Alexander Dobrovic, DNA methylation biomarkers in cancer: progress towards clinical implementation, Expert Review of Molecular Diagnostics, 2012, 12, 5, 473

    CrossRef

  50. 50
    Gayatri Sharma, Sameer Mirza, Rajinder Parshad, Siddartha Datta Gupta, Ranju Ralhan, DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients, Tumor Biology, 2012, 33, 6, 1837

    CrossRef

  51. 51
    M-H Lee, H Na, T-Y Na, Y-K Shin, J-K Seong, M-O Lee, Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis, Oncogenesis, 2012, 1, 9, e25

    CrossRef

  52. 52
    Carolina Oliveira Gigek, Elizabeth Suchi Chen, Danielle Queiroz Calcagno, Fernanda Wisnieski, Rommel Rodriguez Burbano, Marilia Arruda Cardoso Smith, Epigenetic mechanisms in gastric cancer, Epigenomics, 2012, 4, 3, 279

    CrossRef

  53. 53
    M Y Follo, D Russo, C Finelli, S Mongiorgi, C Clissa, C Filì, C Colombi, M Gobbi, L Manzoli, M Piazzi, A M Martelli, L Cocco, Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment, Leukemia, 2012, 26, 5, 943

    CrossRef

  54. 54
    Pablo Menéndez, Pedro Villarejo, David Padilla, José María Menéndez, José Antonio Rodríguez Montes, Epigenética y cáncer colorrectal, Cirugía Española, 2012, 90, 5, 277

    CrossRef

  55. 55
    N. Bachmann, C. Bergmann, Epigenetics and imprinting, Archives de Pédiatrie, 2012, 19, 11, 1145

    CrossRef

  56. 56
    Michael Schnekenburger, Marc Diederich, Epigenetics Offer New Horizons for Colorectal Cancer Prevention, Current Colorectal Cancer Reports, 2012, 8, 1, 66

    CrossRef

  57. You have free access to this content57
    Keisei Okamoto, Epigenetics: A way to understand the origin and biology of testicular germ cell tumors, International Journal of Urology, 2012, 19, 6
  58. 58
    Yufeng Qin, Yankai Xia, Wei Wu, Xiumei Han, Chuncheng Lu, Guixiang Ji, Daozhen Chen, Honghua Wang, Ling Song, Shoulin Wang, Xinru Wang, Genetic variants in microRNA biogenesis pathway genes are associated with semen quality in a Han-Chinese population, Reproductive BioMedicine Online, 2012, 24, 4, 454

    CrossRef

  59. 59
    Fabienne Gumy-Pause, Bruno Pardo, Mary Khoshbeen-Boudal, Marc Ansari, Angèle Gayet-Ageron, André-Pascal Sappino, Edward F. Attiyeh, Hulya Ozsahin, GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma, Genes, Chromosomes and Cancer, 2012, 51, 2
  60. 60
    Xue-Ying Cui, Nan Wang, Bin-Xia Yang, Wei-Feng Gao, Yong-Min Lin, Xing-Rong Yao, Xiao-Tong Ma, HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect, Experimental Hematology, 2012, 40, 1, 14

    CrossRef

  61. 61
    Hironobu Shigaki, Yoshifumi Baba, Masayuki Watanabe, Shiro Iwagami, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Hideo Baba, LINE-1 Hypomethylation in Noncancerous Esophageal Mucosae is Associated with Smoking History, Annals of Surgical Oncology, 2012, 19, 13, 4238

    CrossRef

  62. 62
    Xia Liu, Xiuming Tang, Shaoyan Zhang, Yun Wang, Xiaofeng Wang, Chengquan Zhao, Bing Luo, Methylation and Expression of Retinoblastoma and Transforming Growth Factor-β1 Genes in Epstein-Barr Virus-Associated and -Negative Gastric Carcinomas, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

  63. 63
    William CS Cho, MicroRNAs as therapeutic targets and their potential applications in cancer therapy, Expert Opinion on Therapeutic Targets, 2012, 16, 8, 747

    CrossRef

  64. 64
    Michael Rossbach, MicroRNAs in cancer therapy, Expert Opinion on Therapeutic Targets, 2012, 16, 8, 743

    CrossRef

  65. 65
    Gajendra K. Azad, Shah Jaimin Balkrishna, Narayanan Sathish, Sangit Kumar, Raghuvir S. Tomar, Multifunctional Ebselen drug functions through the activation of DNA damage response and alterations in nuclear proteins, Biochemical Pharmacology, 2012, 83, 2, 296

    CrossRef

  66. 66
    Anna M. Jankowska, Hadrian Szpurka, Mutational Determinants of Epigenetic Instablity in Myeloid Malignancies, Seminars in Oncology, 2012, 39, 1, 80

    CrossRef

  67. 67
    Shiro Iwagami, Yoshifumi Baba, Masayuki Watanabe, Hironobu Shigaki, Keisuke Miyake, Satoshi Ida, Yohei Nagai, Takatsugu Ishimoto, Masaaki Iwatsuki, Yasuo Sakamoto, Yuji Miyamoto, Hideo Baba, Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, 2012, 19, 8, 2726

    CrossRef

  68. 68
    Shinichiro Akiyama, Ariko Yamauchi, Teruyo Yamashita, Hiroshi Nimura, Hiroyuki Abe, Retrospective analysis of the clinical efficacy of a dendritic cell-based cancer vaccine in patients with advanced or recurrent breast cancer, Personalized Medicine Universe, 2012, 1, 1, 25

    CrossRef

  69. 69
    Sofia Lisanti, Thomas von Zglinicki, John C. Mathers, Standardization and quality controls for the methylated DNA immunoprecipitation technique, Epigenetics, 2012, 7, 6, 615

    CrossRef

  70. 70
    Paolo Di Fruscia, Ka-Kei Ho, Sasiwan Laohasinnarong, Mattaka Khongkow, Sebastian H. B. Kroll, Suhail A. Islam, Michael J. E. Sternberg, Karin Schmidtkunz, Manfred Jung, Eric W.-F. Lam, Matthew J. Fuchter, The discovery of novel 10,11-dihydro-5H-dibenz[b,f]azepine SIRT2 inhibitors, MedChemComm, 2012, 3, 3, 373

    CrossRef

  71. 71
    Jie Yang, Wen Gao, Ning-Hong Song, Wei Wang, Jie-Xiu Zhang, Pei Lu, Li-Xin Hua, Min Gu, The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis, Asian Journal of Andrology, 2012, 14, 5, 726

    CrossRef

  72. 72
    Walter Pulverer, Matthias Wielscher, Renate Panzer-Grümayer, Tanja Plessl, Albert Kriegner, Klemens Vierlinger, Andreas Weinhäusel, The stem cell signature of CHH/CHG methylation is not present in 271 cancer associated 5′UTR gene regions, Biochimie, 2012, 94, 11, 2345

    CrossRef

  73. 73
    Wei Cao, Zhien Feng, Zhibin Cui, Chenping Zhang, Zhaoyao Sun, Li Mao, Wantao Chen, Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma, Cancer, 2012, 118, 11
  74. 74
    Li-Yuan Bai, Chang-Fang Chiu, Shiow-Lin Pan, Aaron M. Sargeant, Tzong-Ming Shieh, Ying-Chu Wang, Jing-Ru Weng, Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma, Oral Oncology, 2011, 47, 12, 1127

    CrossRef

  75. 75
    Mariana Brait, David Sidransky, Cancer epigenetics: above and beyond, Toxicology Mechanisms and Methods, 2011, 21, 4, 275

    CrossRef

  76. 76
    Yasuhiro Oki, Amanda Copeland, Anas Younes, Clinical development of panobinostat in classical Hodgkin’s lymphoma, Expert Review of Hematology, 2011, 4, 3, 245

    CrossRef

  77. 77
    Q. Gao, E. J. Steine, M. I. Barrasa, D. Hockemeyer, M. Pawlak, D. Fu, S. Reddy, G. W. Bell, R. Jaenisch, Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression, Proceedings of the National Academy of Sciences, 2011, 108, 44, 18061

    CrossRef

  78. 78
    Mary Beth Terry, Lissette Delgado-Cruzata, Neomi Vin-Raviv, Hui Chen Wu, Regina M. Santella, DNA methylation in white blood cells, Epigenetics, 2011, 6, 7, 828

    CrossRef

  79. 79
    Tabitha M Hardy, Trygve O Tollefsbol, Epigenetic diet: impact on the epigenome and cancer, Epigenomics, 2011, 3, 4, 503

    CrossRef

  80. 80
    J. Katto, U. Mahlknecht, Epigenetic regulation of cellular adhesion in cancer, Carcinogenesis, 2011, 32, 10, 1414

    CrossRef

  81. 81
    Feng-Feng Cai, Corina Kohler, Bei Zhang, Ming-Hong Wang, Wei-Jie Chen, Xiao-Yan Zhong, Epigenetic Therapy for Breast Cancer, International Journal of Molecular Sciences, 2011, 12, 12, 4465

    CrossRef

  82. 82
    Jean-Pierre Issa, Wilhelm Just, Epigenetics, FEBS Letters, 2011, 585, 13, 1993

    CrossRef

  83. 83
    Nicole Engel, Andreas Rank, Epigenomics in hematopoietic transplantation: novel treatment strategies, Epigenomics, 2011, 3, 5, 611

    CrossRef

  84. 84
    Linda B. C. Bralten, Pim J. French, Genetic Alterations in Glioma, Cancers, 2011, 3, 4, 1129

    CrossRef

  85. You have free access to this content85
    Fumiaki Sato, Soken Tsuchiya, Stephen J. Meltzer, Kazuharu Shimizu, MicroRNAs and epigenetics, FEBS Journal, 2011, 278, 10
  86. 86
    María Cortés-Sempere, Inmaculada Ibáñez de Cáceres, microRNAs as novel epigenetic biomarkers for human cancer, Clinical and Translational Oncology, 2011, 13, 6, 357

    CrossRef

  87. 87
    Kyriaki Bakirtzi, Maria Hatziapostolou, Iordanes Karagiannides, Christos Polytarchou, Savina Jaeger, Dimitrios Iliopoulos, Charalabos Pothoulakis, Neurotensin Signaling Activates MicroRNAs-21 and -155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors, Gastroenterology, 2011, 141, 5, 1749

    CrossRef

  88. 88
    Eun-Young Park, Yu-Mi Woo, Jong-Hoon Park, Polycystic kidney disease and therapeutic approaches, BMB Reports, 2011, 44, 6, 359

    CrossRef

  89. 89
    S. Deneberg, P. Guardiola, A. Lennartsson, Y. Qu, V. Gaidzik, O. Blanchet, M. Karimi, S. Bengtzen, H. Nahi, B. Uggla, U. Tidefelt, M. Hoglund, C. Paul, K. Ekwall, K. Dohner, S. Lehmann, Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks, Blood, 2011, 118, 20, 5573

    CrossRef

  90. 90
    Thomas I. Peng Soh, Wei Peng Yong, Federico Innocenti, Recent progress and clinical importance on pharmacogenetics in cancer therapy, Clinical Chemistry and Laboratory Medicine, 2011, 49, 10

    CrossRef

  91. 91
    Ji-hang Yuan, Fu Yang, Bi-feng Chen, Zhi Lu, Xi-song Huo, Wei-ping Zhou, Fang Wang, Shu-han Sun, The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma, Hepatology, 2011, 54, 6
  92. 92
    Axel Schulenburg, Brigitte Marian, Normal and Neoplastic Stem Cells, Encyclopedia of Molecular Cell Biology and Molecular Medicine,